


Ask a doctor about a prescription for BISOPROLOL TEVA 2.5 mg TABLETS
Package Leaflet: Information for the User
Bisoprolol Teva 2.5 mg Tablets EFG
bisoprolol fumarate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
|
Contents of the Package Leaflet
Bisoprolol Teva contains the active substance bisoprolol fumarate. Bisoprolol belongs to a group of medicines called beta-blockers. Bisoprolol prevents irregular heartbeats (arrhythmia) during stress and decreases the cardiovascular workload. Bisoprolol also dilates blood vessels and thus facilitates blood flow.
Bisoprolol is used to:
Do not take Bisoprolol Teva
Warnings and precautions
Tell your doctor or pharmacist before taking this medicine, they may want to take special precautions (e.g., provide additional treatment or perform more frequent tests):
If you have chronic pulmonary disease or less severe asthma, inform your doctor immediately if you start to notice breathing difficulties, cough, wheezing after exercise, etc., while using bisoprolol.
Children and adolescents
This medicine is not recommended for use in children or adolescents.
Other medicines and Bisoprolol Teva
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Do not take the following medicines with Bisoprolol Teva without special advice from your doctor:
However, do not stop taking these medicineswithout consulting your doctor first.
Consult your doctor before taking the following medicines with Bisoprolol Teva; your doctor may need to monitor your condition more frequently:
Non-steroidal anti-inflammatory medicines such as acetylsalicylic acid, diclofenac, ibuprofen, ketoprofen, naproxen, celecoxib, or etoricoxib (especially if used long-term or regularly) may reduce the effectiveness of bisoprolol in treating hypertension. However, small daily doses of acetylsalicylic acid, e.g., 100 mg, can be used safely in combination with bisoprolol to prevent blood clots.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Bisoprolol should not be used during pregnancy unless clearly necessary. If you are pregnant or planning to become pregnant during treatment with bisoprolol, inform your doctor so that they can advise you on appropriate treatment.
It is not known whether bisoprolol is excreted in breast milk. Therefore, breastfeeding is not recommended during use of this medicine.
Driving and using machines
Bisoprolol has a minimal or non-existent impact on the ability to drive. Adverse effects related to a drop in blood pressure may include dizziness, headache, fatigue, or other adverse effects (see section 4) that may affect the ability to drive or operate machines. If you experience these adverse effects, do not drive vehicles and/or operate machines that require your full attention. In particular, attention is required at the start of treatment and after increasing the dose. Bisoprolol normally does not affect the ability to drive if the treatment is well balanced.
Bisoprolol Teva contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is
Adults:
For treating hypertension and angina pectoris
For treating stable chronic heart failure
Treatment with bisoprolol should be started at a low dose and gradually increased. Your doctor will decide how to increase the dose, and this will usually be done as follows:
The maximum recommended daily dose is 10 mg of bisoprolol.
Depending on how well you tolerate the medicine, your doctor may also decide to prolong the time between dose increases. If your condition worsens or you no longer tolerate the medicine, it may be necessary to reduce the dose again or stop treatment. In some patients, a maintenance dose lower than 10 mg of bisoprolol may be sufficient. Your doctor will tell you what to do. Normally, if you need to stop treatment completely, your doctor will advise you to gradually reduce the dose, as otherwise, your condition may worsen.
Elderly patients
No dose adjustment is necessary in elderly patients unless they have renal or hepatic impairment, see below.
Patients with renal or hepatic impairment
The dose should be increased gradually and with caution in patients with severe liver or kidney problems. The dose should not exceed 10 mg once daily in patients with severe renal or hepatic impairment.
Method of administration
Swallow the tablets with sufficient liquid (e.g., a glass of water) usually once daily in the morning. The tablets should not be chewed. Food does not affect the absorption of the medicine.
The tablet can be divided into equal doses. Divide the tablets as follows: place the tablets with the break line facing up on a flat, hard surface (e.g., a table) and divide the tablets by pressing with the index fingers of both hands to the right and left of the break line on the outer part of the tablet towards the surface.
If you take more Bisoprolol Teva than you should
If you have taken an overdose of Bisoprolol Teva, consult your doctor or a hospital immediately.
In case of nausea or dizziness, place the patient in a lying position and seek medical assistance. An unconscious patient should be placed in a recovery position; however, the legs may be elevated.
In case of overdose or accidental ingestion, consult the Toxicological Information Service. Telephone 91 562 04 20, indicating the medicine and the amount taken. It is recommended to bring the packaging and the package leaflet of the medicine to the healthcare professional.
If you forget to take Bisoprolol Teva
Take the next tablet at the usual time. Do not take a double dose or a larger dose to make up for forgotten doses.
If you stop taking Bisoprolol Teva
Treatment should not be stopped abruptly, especially when the patient has ischemic heart disease. The dose should be reduced slowly, e.g., over 1-2 weeks. Otherwise, the symptoms of heart disease may worsen.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
To prevent serious adverse reactions, talk to a doctor immediately if an adverse effect is severe, occurs suddenly, or worsens rapidly.
The most serious adverse effects are related to heart function, among them, the most common adverse effects have been slowing of the heart rate, excessive decrease in blood pressure, dizziness, and fatigue.
Other adverse effects are mentioned below according to their frequency of possible occurrence:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the packaging and blister after "EXP". The expiry date is the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Bisoprolol Teva 2.5 mg tablets
The active ingredient is bisoprolol fumarate
Each Bisoprolol Teva 2.5 mg tablet contains 2.5 mg of bisoprolol fumarate.
The other components are: microcrystalline cellulose (E 460), anhydrous colloidal silica, sodium croscarmellose, sodium carboxymethyl starch type A (derived from potato) and magnesium stearate (E 572).
Appearance of the product and container content
Bisoprolol Teva 2.5 mg tablets are white to off-white, round, biconvex tablets with a score line on one side.
The containers include 20, 21, 28, 30, 50, 56, 60, 90 or 100 tablets
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Teva Pharma, S.L.U.
Anabel Segura 11, Edificio Albatros B, 1st floor
28108 Alcobendas, Madrid
Manufacturer:
Chanelle Medical Unlimited Company
Dublin Road, Loughrea, H62 FH90,
Ireland
Or
Merckle GmbH
Ludwig-Merckle-Straße 3
89143 Blaubeuren
Germany
This medicinal product is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names
Germany: Bisoprolol AbZ 2.5 mg Tabletten
Belgium: Bisoprolol Teva 2.5 mg tablets
Spain: Bisoprolol Teva 2.5 mg tablets EFG
Netherlands: Bisoprololfumaraat 2.5 mg Teva, tablets
Italy: Bisoprololo Doc 2.5 mg compressa
Sweden: Bisoprolol Teva 2.5 mg tablets
United Kingdom (Northern Ireland): Bisoprolol Fumarate 2.5 mg tablets
Date of the last revision of this leaflet: May 2024
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of BISOPROLOL TEVA 2.5 mg TABLETS in November, 2025 is around 2.4 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for BISOPROLOL TEVA 2.5 mg TABLETS – subject to medical assessment and local rules.